Genetic Association of CYP1B1 4326 C>G Polymorphism with Disease-Free Survival in TNBC Patients Undergoing TAC Chemotherapy Regimen

BACKGROUND: Triple negative breast cancer (TNBC) which is treated with taxane, adriamycin and cyclophosphamide (TAC) chemotherapy regimen show variation in treatment response. CYP1B1 4326 C>G polymorphism has been implicated in contributing to the differences in treatment response in various type...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Asian Pac J Cancer Prev
Hauptverfasser: Abdul Aziz, Ahmad Aizat, Md Salleh, Md Salzihan, Yahya, Maya Mazuwin, Zakaria, Andee Dzulkarnaen, Ankathil, Ravindran
Format: Artigo
Sprache:Inglês
Veröffentlicht: West Asia Organization for Cancer Prevention 2021
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8325143/
https://ncbi.nlm.nih.gov/pubmed/33906328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2021.22.4.1319
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge